Latest | Instant Finance & Market News_第314页 | NewTimeSpace

07:45

[ SKB BIO-B(06990.HK): Proposed Placing of 5.838 Million New H-Shares, Estimated Net Proceeds of Approximately HK$2.723 Billion ] NewTimeSpace News: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (06990.HK) announced that it entered into a placing agreement with the placing agents on 8 July 2026. The Company proposes to place 5,838,000 new H-shares at a placing price of HK$470.20 per share, representing a discount of approximately 8.52% to the closing price of HK$514 on the last trading day. The total gross proceeds will be about HK$2.745 billion, with estimated net proceeds of roughly HK$2.723 billion, to be deployed for product R&D, clinical trials, commercialisation and supplementing working capital.

Tag： SKB BIO-B 06990.HK H-share placement

07:38

[ GUOXIA TECH(02655.HK): Signs Strategic Framework Agreement with Sweden’s Rocmore Energy to Expand European Energy Storage Market ] NewTimeSpace News: Guoxia Technology Co., Ltd. (02655.HK) announced that it entered into a Strategic Cooperation Framework Agreement with Rocmore Energy AB at the end of June 2026. The two parties intend to establish a long-term strategic partnership, integrating the Group’s energy storage solutions with Rocmore’s Nordic projects to jointly serve the Nordic region and broader European markets.

Tag： GUOXIA TECH 02655.HK strategic cooperation

22:08

[ CVTE Resubmits HKEX Listing Application for the Third Time; seewo Education Interactive Flat Panels Rank No.1 Globally ] NewTimeSpace News: Guangzhou Shiyuan Electronic Technology Company Limited (002841.SZ) submitted its third listing application to the Hong Kong Stock Exchange on 7 July, with CICC and GF Securities acting as joint sponsors. According to Frost & Sullivan data, the Company’s seewo-branded education interactive flat panels captured a 17.0% global market share by revenue, ranking first worldwide in 2025; its MAXHUB-branded conference interactive flat panels held a 25.0% market share in mainland China (1st) and 8.7% globally (2nd); LCD display driver control boards secured a 24.4% global market share by shipment volume, topping the world ranking.

Tag： CVTE 002841.SZ A+H IPO

21:58

[ JIANGXI COPPER(00358.HK): Chairman Zheng Gaoqing Resigns Upon Reaching Statutory Retirement Age ] NewTimeSpace News: Jiangxi Copper Company Limited (00358.HK) announced that the Board of Directors received a written resignation notice from Executive Director Mr. Zheng Gaoqing on 7 July 2026. Having reached the statutory retirement age, Mr. Zheng tendered his resignation from the posts of Chairman, Executive Director, Chairman of the Nomination Committee and Chairman of the ESG Development Committee, and will cease to hold any position within the Company.

Tag： JIANGXI COPPER 00358.HK retire

21:39

[ NANHUA FUTURES(02691.HK): Resolution to Close Harbin Business Department; Businesses to Be Undertaken by Heilongjiang Branch ] NewTimeSpace News: Nanhua Futures Co.,Ltd. (02691.HK) announced that to further optimise its network layout of business outlets and integrate operating resources, the Company has resolved to close its Harbin Business Department, with all its businesses to be taken over by the Heilongjiang Branch.

Tag： NANHUA FUTURES 02691.HK Business Department Closure

21:30

[ NEXCHIP(02249.HK): English Corporate Name Changed to Nexchip Semiconductor Corporation ] NewTimeSpace News: Hefei Nexchip Integrated Circuit Co., Ltd. (02249.HK) announced that the Companies Registry of Hong Kong has issued a Certificate of Registration of Change of Name for a Registered Non-Hong Kong Company. The Company’s English name has been altered from “Nexchip Semiconductor (China) Limited” to “Nexchip Semiconductor Corporation”, with effect from 6 July 2026.

Tag： Nexchip 02249.HK Corporate Name Change

21:27

[ HENGRUI PHARMA (01276.HK): SHR-4685 Injection Obtains Clinical Trial Approval for Advanced Solid Tumours ] NewTimeSpace News: Jiangsu Hengrui Pharmaceuticals Co.,Ltd (01276.HK) announced that its subsidiary Suzhou Shengdiya Biopharmaceuticals has received the Drug Clinical Trial Approval Letter for SHR-4685 Injection issued and approved by the National Medical Products Administration (NMPA), authorising monotherapy clinical trials of the product in patients with advanced solid tumours. This innovative anti-tumour drug is independently developed by the Group, and no similar drugs have been approved for marketing at home or abroad to date.

Tag： HENGRUI PHARMA 01276.HK Clinical Trial Application

21:18

[ Mabwell-B(02493.HK): IND Application of 9MW5211 Injection for Type 1 Diabetes Mellitus Accepted by NMPA ] NewTimeSpace News: Mabwell (Shanghai) Bioscience Co., Ltd. (02493.HK) announced that the clinical trial application for 9MW5211 Injection indicated for Type 1 Diabetes Mellitus (T1DM) has been approved by the National Medical Products Administration (NMPA). Previously, its clinical trial application for Inflammatory Bowel Disease (IBD) was granted approval by both NMPA and the U.S. Food and Drug Administration (FDA), while the application for Multiple Sclerosis (MS) also obtained NMPA clearance.

Tag： MABWELL-B 02493.HK Clinical Trial

20:01

[ CSPC PHARMA(01093.HK): Phase II Clinical Trial of SYH2070 Injection for Mixed Hyperlipidaemia Initiated at First Clinical Site in China ] NewTimeSpace News: CSPC Pharmaceutical Group Limited (01093.HK) announced that the Phase II clinical trial of self-developed SYH2070 Injection for the treatment of mixed hyperlipidaemia has officially kicked off at the first clinical centre in China. As an siRNA drug targeting ANGPTL3 mRNA, the candidate delivers sustained and stable reduction of triglycerides and low-density lipoprotein cholesterol simultaneously.

Tag： CSPC PHARMA 01093.HK Clinical Trial

19:23

[ SC HOLDINGS(00413.HK): Two Winding-up Petitions Filed Against Subsidiary Wah Shing Toys, Total Amount Involved Approximately HK$8.72 Million ] NewTimeSpace News: South China Holdings Company Limited (00413.HK) announced that Wah Shing Toys Limited, its indirectly wholly-owned subsidiary, received two winding-up petitions on 17 June and 18 June 2026 respectively, involving outstanding payments totalling around HK$8.72 million, with both hearings scheduled for 2 September 2026. As at the date of the announcement, no winding-up order has been issued by the High Court.

Tag： SC HOLDINGS 00413.HK Winding Up Petition

19:18

[ HENDERSON INV(00097.HK): Independent Non-executive Director Mr. Kwong Chi Keung Passed Away ] NewTimeSpace News: Henderson Investment Ltd. (00097.HK) announced that Mr. Kwong Chi Keung, Independent Non-executive Director, Chairman of the Audit Committee and Corporate Governance Committee, Member of the Remuneration Committee and Nomination Committee, passed away on 6 July 2026. Mr. Kwong had served as a Director since 2004 for a term of 22 years. Ms. Xu Min has been appointed Chairman of the Audit Committee and Member of the Remuneration Committee, while Mr. Wu King Cheong has been appointed Chairman of the Corporate Governance Committee.

Tag： HENDERSON INV 00097.HK Passed Away

19:04

[ HANXBIO-B(03378.HK): Signs AI Drug R&D Cooperation Agreement with Frontier Interdisciplinary Research Center of Huazhong University of Science and Technology ] NewTimeSpace News: Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (03378.HK) announced that it has formally signed a cooperation agreement to jointly build a Joint Laboratory for AI-Driven Drug Discovery with the Frontier Interdisciplinary Research Center of HUST-CityU Advanced Research Institute. The two parties will carry out in-depth cooperation focusing on antibody discovery and molecular design to jointly establish a new generation AI-powered innovative drug research and development paradigm.

Tag： HANXBIO-B 03378.HK cooperation

18:12

[ KN HOSPITAL(02120.HK): HKEX Grants Listing Approval for H-Share Full Circulation; Approximately 9.286 Million Domestic Shares to Be Converted into H-Shares ] NewTimeSpace News: Wenzhou Kangning Hospital Co., Ltd. (02120.HK) announced that it has obtained approval from the Stock Exchange of Hong Kong Limited granted on 6 July 2026 for the listing of and permission to deal in 9,286,359 converted H-shares arising from the conversion of domestic shares held by six participating shareholders. Upon completion of the conversion and listing, the proportion of H-shares will rise from 27.09% to 39.92%.

Tag： KN HOSPITAL 02120.HK H-share full circulation

18:00

[ SKB BIO-B(06990.HK): Joint Company Secretary Chung Ming Fai Resigns; Zhou Zejian to Serve as Sole Company Secretary ] NewTimeSpace News: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (06990.HK) announced that the Stock Exchange of Hong Kong has confirmed Mr. Zhou Zejian satisfies the qualifications to act as the Company Secretary. Mr. Chung Ming Fai resigned as Joint Company Secretary and Authorised Representative, effective 11 July 2026. Upon his resignation, Mr. Zhou Zejian will become the sole Company Secretary and Authorised Representative of the Company.

Tag： SKB BIO-B 06990.HK resignation

17:55

[ LuxshareICT(02475.HK): Offer Price Fixed at HK$63.28, Listing Scheduled for 9 July ] NewTimeSpace News: Luxshare Precision Industry Co., Ltd. (02475.HK) announced its offer price, with the H-share offer price set at HK$63.28 per share (excluding relevant fees). The Company expects trading to commence on the Main Board of the Stock Exchange of Hong Kong Limited at 9:30 a.m. on 9 July 2026, with each board lot comprising 100 shares.

Tag： LUXSHARE ICT 02475.HK IPO

17:50

[ TONGRENTANGCARE(02667.HK)：The stock fell 39.09% on its first trading day, closing at HK$3.35. ] NewTimeSpace News: By the close of trading on Jul 7, 2026, TONGRENTANGCARE(02667.HK) saw a loss of 39.09% in its share price, closing at HKD 3.35. During the session, it reached an intraday high of HKD 4.79 and touched an intraday low of HKD 3.01.

Tag： TONGRENTANGCARE 02667.HK closing price

17:46

[ TIMES CHINA(01233.HK): Contracted Sales Reach Approximately RMB1.831 Billion in First Half ] NewTimeSpace News: Times China Holdings Limited (01233.HK) announced that the Group’s aggregate contracted sales (including sales from joint venture projects) for the six months ended 30 June 2026 stood at approximately RMB1.831 billion, with contracted gross floor area of roughly 186,900 sq.m. Contracted sales for June alone totalled about RMB310 million, covering contracted gross floor area of around 32,100 sq.m.

Tag： TIMES CHINA 01233.HK sales data

17:43

[ Honghua Group Limited (00196.HK): Profit Warning, Expected Interim Loss of RMB 20 Million to RMB 40 Million ] NewTimeSpace News: Honghua Group Limited disclosed in an announcement dated July 7 that the Group expects to record a loss attributable to shareholders of approximately RMB 20 million to RMB 40 million for the six months ended 30 June 2026.

Tag： Honghua Group Limited 00196.HK

17:40

[ EVEREST MED(01952.HK): Closing Completed for Exclusive Licensing Collaboration with Travere; Upfront Payment of USD112.5 Million ] NewTimeSpace News: Everest Medicines Limited (01952.HK) announced the completion of closing under the exclusive licensing and collaboration agreement entered into with Travere Therapeutics, Inc. The licensor will receive an upfront payment of USD112.5 million, and is eligible to receive aggregate development, regulatory and commercial milestone payments of up to USD1.03 billion across a maximum of five indications, as well as tiered royalties based on future annual net sales.

Tag： EVEREST MED 01952.HK cooperation

17:40

[ Greater China Financial (00431.HK): Cancellation of Listing Status ] NewTimeSpace News: The Stock Exchange of Hong Kong Limited announced that the listing status of Greater China Financial Holdings Limited will be cancelled with effect from 9:00 a.m. on 9 July 2026.

Tag： Greater China Financial 00431.HK

Scan QR Code

Download App